Here's their timeline from the last AGM in November (with some annotations I made at the time). Outrageously ridiculous which many of us knew at the time.
Also, I know the company sometimes referred to these phase 1 trials as sepsis trials, but we need to keep in mind that they are simply IV formulation trials. Sepsis is off the table for now I believe due to poor plasma concentrations. UTI our best bet for this formulation, but we'll need to see how actual patients respond in the coming phase 2.
RCE Price at posting:
47.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)